Indiana Administrative Code
Title 844 - MEDICAL LICENSING BOARD OF INDIANA
Article 2.2 - PHYSICIAN ASSISTANTS
Rule 3 - Opioid Prescribing Requirements
Section 3-8 - Drug monitoring testing
Current through March 20, 2024
Authority: IC 25-22.5-2-7; IC 25-22.5-13-3
Affected: IC 25-1-9; IC 25-27.5
Sec. 8.
(a) At any time the physician assistant determines that it is medically necessary, whether at the outset of an opioid treatment plan, or any time thereafter, a physician assistant prescribing opioids for a patient shall perform or order a drug monitoring test, which must include a confirmatory test using a method selective enough to differentiate individual drugs within a drug class, on the patient.
(b) In determining whether a drug monitoring test under subsection (a) is medically necessary, the physician assistant shall consider, subject to the provisions of subsection (c), each of the following factors where applicable and reasonably feasible:
(c) It shall not be considered a violation of this section for a physician assistant to fail to conduct a review of all eighteen (18) factors listed in subsection (b) if the physician assistant reasonably determines following a review of less than all of the factors listed in subsection (b) that a drug monitoring test is medically necessary.
(d) Nothing about subsection (b) shall be construed to prohibit the physician assistant from performing or ordering a drug monitoring test at any other time the physician assistant considers appropriate.
(e) If a test performed under subsection (a), or conducted under subsection (d), reveals inconsistent medication use patterns or the presence of illicit substances, a review of the current treatment plan shall be required. Documentation of the revised treatment plan and discussion with the patient must be recorded in the patient's chart.